CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GILD

Single dose liposomal Amphotericin and Fluconazole

Phase 3
Gilead Sciences, Inc. (GILD)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jun '27
GILDPhase 3

Single dose liposomal Amphotericin and Fluconazole Phase 3 Est. Readout (ACACIA)

Single dose liposomal Amphotericin and Fluconazole
Jun 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Cryptococcal Meningitis

View Full Landscape
Drug Information

Target Indication

Cryptococcal Meningitis

Clinical Trial

NCT03945448

Last updated: 10/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.